On behalf of an established Alacrita client, a publicly traded clinical stage biotechnology company with a cell therapy platform technology, we assessed the potential of a novel extracellular vesicle technology across a range of potential applications. The technology, which had been developed in-house, was based on vesicles produced from stem cells. The client asked Alacrita to assess the competitiveness of its technology and, if appropriate, to develop a strategy based on selected applications/disease indications.


Alacrita assembled a multidisciplinary team to conduct a phased work-plan involving:

  • Identification of sustainable differentiators within the extracellular vesicle landscape
  • Generating a long list of strategic options and associated product opportunities
  • Triaging, characterizing and prioritizing the potential opportunities based on a combination of commercial attractiveness and technology fit
  • Synthesize the conclusions into an actionable strategy.
Through a series of workshop meetings with the client team, we developed a consensus which the client team presented to it Board.

Opportunity Mapping Services

We can help you gauge and rank the opportunities for your R&D programs or technology platforms to deliver value, by framing the commercial potential and charting the path to market.


Related Case Studies | View all